MEG3 and Parkinson disease: Furthermore, Quan et al. found that the expression level of maternally expressed gene-3 (MEG3) in the plasma of PD patients was lowereed than that of the anti-control group, and revealed the possibility of lncRNA MEG3 as a new candidate biomarker for PD (Quan et al., 2020).